Cognizant Secures Major $1 Billion Deal with Novartis

Overview of the Deal

BENGALURU: Cognizant has successfully secured a contract exceeding $1 billion from Swiss pharmaceutical giant Novartis. This significant agreement is part of a consolidation contract that encompasses both renewals and new projects in areas such as application services, infrastructure, and AI-driven solutions.

Previous Billion-Dollar Contract

This marks the second consecutive billion-dollar agreement for Cognizant in under a year, following a major contract win with UnitedHealth Group last year. UnitedHealth is one of Cognizant’s largest clients, benefiting from a partnership that spans nearly two decades.

Company Response

When approached for comment, a Cognizant spokesperson stated that the company is currently in a silent period and could not provide any additional details. An inquiry sent to Novartis did not receive a response by the time of publication.

Key Players in Securing the Deal

Insiders indicate that Cognizant’s teams in the EMEA and APAC regions were instrumental in securing this lucrative contract. The deal was notably supported by Gagan Syal, who leads Cognizant’s life sciences division in these regions.

Market Trends in IT Services

According to Phil Fersht, CEO of USIT advisory HfS Research, the increase in large-scale IT services agreements reflects a fundamental shift in how companies procure technology. CIOs are actively consolidating vendors, merging what were previously multiple mid-sized contracts into fewer, more comprehensive, and longer-term engagements with enhanced accountability. These contracts typically span seven to ten years, indicating a strategic approach to vendor management.

This revamped content not only provides clarity and organization but also incorporates SEO-friendly elements, such as relevant subheadings and keywords related to the topic.